JENNIFER W BAKER, PHARM.D.
Pharmacy in Murfreesboro, TN

License number
Tennessee 012921
Category
Pharmacy
Type
Pharmacist
License number
Tennessee 0000024432
Category
Pharmacy
Type
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Address
Address 2
3400 Lebanon Pike, Murfreesboro, TN 37129
1310 24Th Ave S, Nashville, TN 37212
Phone
(615) 867-6000
(615) 327-4751

Organization information

See more information about JENNIFER W BAKER at bizstanding.com

Jennifer W Baker

3400 Lebanon Rd, Murfreesboro, TN 37129

Categories:
Science of Mind Churches
Phone:
(615) 867-6000 (Phone)

Professional information

Jennifer Baker Photo 1

Get Engaged Consulting

Position:
Owner at Get Engaged
Location:
Greater Nashville Area
Industry:
Financial Services
Work:
Get Engaged since Jan 2011 - Owner Fifth Third Bank May 2006 - Dec 2010 - CRA Manager I AmSouth Bank 2000 - 2003 - Private Banking Associate
Education:
Alabama Agricultural and Mechanical University 1993 - 1997
Bachelor of Science (BS), Marketing
Baker High School, Mobile AL 1989 - 1993


Jennifer C Baker Photo 2

Jennifer C Baker, Nashville TN - APRN

Specialties:
Nursing (Nurse Practitioner), Gerontology Nursing (Nurse Practitioner)
Address:
Vanderbilt Medical Ctr, Nashville 37232
(615) 776-8930 (Phone)
Languages:
English


Jennifer Baker Photo 3

Use Of Nucleic Acid Probes To Detect Nucleotide Sequences Of Interest In A Sample

US Patent:
2009020, Aug 13, 2009
Filed:
Jan 23, 2009
Appl. No.:
12/359263
Inventors:
ELLIOTT P. DAWSON - MURFREESBORO TN, US
STEVEN J. SIMMONS - UNIONVILLE TN, US
LORI J. RAY-COX - MURFREESBORO TN, US
JENNIFER M. BAKER - NASHVILLE TN, US
KRISTIE E. WOMBLE - FRANKLIN TN, US
JUDITH MADDEN - VALENCIA CA, US
SUBRAMANI SELLAPPAN - AURORA IL, US
ANDREW HEARN - CHICAGO IL, US
SAL SEMINARA - CHICAGO IL, US
Assignee:
BLOVENTURES, INC. - MURFREESBORO TN
Celsis International plc - Chicago IL
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The invention relates to methods for the determination and detection of nucleic acids sequences in a sample. The nucleic acid may be RNA or DNA or both. The invention also relates to methods for the determination of the presence and species of various microorganisms in a sample. We have also identified a set of oligonucleotide nucleic acid sequences within the rRNAs of Gram-negative organisms that facilitates both the broad identification of Gram-negative organisms as a class when used as a pool, or in combination, for example in a hybridization assay. This set of oligonucleotides may detect sequences that are indicative of the presence of organisms of the broad class of Gram-negative organisms while exhibiting little or no false identification of Gram-positive organisms, and fungi, or other microorganisms. The assay includes concurrent incubation with at least one nucleotide sequence of interest, at least one nucleic acid probe, a fluorosurfactant, and a nuclease. The assay may further be employed to detect the presence of bacteria, fungi, or other microorganisms by use of additional specific probes, or to detect and/or identify target nucleic acid sequences in a sample. Further, the invention also relates to methods of reducing non-specific binding and facilitating complex formation in a binding assay. The binding assay may be, but is not limited to, a nucleic acid hybridization assay or an immunoassay. The invention also relates to methods of detection that employ at least one target of interest, which may be a nucleotide sequence, at least one probe, which may be a nucleic acid probe and a nuclease.